文献速递前列腺癌泌尿系感染

HIV感染者前列腺癌筛查与发病率研究

Prostate Cancer Screening and Incidence among Aging Persons Living with HIV.
PubMed 文献 · J Urol · 2021-09-24

在退伍军人老龄化队列研究中,123,472名男性(37,819名HIV感染者与85,653名匹配对照)显示HIV感染者PSA检测率较低(0.58 vs 0.63次/人年)。校正PSA检测后,两组前列腺癌发病率相似(IRR=0.93,95%CI 0.86-1.01,p=0.08)。

要点

  • HIV感染者PSA筛查率较低,粗发病率也较低
  • 校正PSA检测后,前列腺癌发病率无显著差异
  • 活检后癌症检出率及分期无显著差异,但Gleason分级分布有差异

核心结论

  • 校正PSA检测差异后,HIV感染者与未感染者的前列腺癌发病率相似,提示筛查不足导致了观察到的较低发病率。

研究设计与样本

  • 前瞻性全国队列研究(退伍军人老龄化队列研究),纳入2000-2015年123,472名男性,其中37,819名HIV感染者,85,653名人口学匹配的未感染对照。

主要发现

  • HIV感染者PSA检测率较低(0.58 vs 0.63次/人年),调整后PSA筛查率IRR 0.87(95%CI 0.75-0.84),活检率IRR 0.79(95%CI 0.74-0.83)。
  • 前列腺癌粗发病率IRR 0.90(95%CI 0.83-0.97),但校正PSA检测后IRR=0.93(95%CI 0.86-1.01,p=0.08)。
  • 活检者中前列腺癌发病率无显著差异(IRR 1.06,95%CI 0.98-1.15,p=0.15)。
  • incident cancers中,Gleason分级分布有显著差异(p=0.05),但分期无显著差异(p=0.14)。

临床怎么用

  • 对于HIV感染者,应关注前列腺癌筛查机会,避免因筛查不足导致发病率被低估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The risk of prostate cancer among persons living with human immunodeficiency virus (PWH) is not well understood and may be obscured by different opportunities for detection. MATERIALS AND METHODS: We identified 123,472 (37,819 PWH and 85,653 comparators) men enrolled in the Veterans Aging Cohort Study, a prospective national cohort of PWH and demographically matched, uninfected comparators in 2000-2015. We calculated rates of prostate specific antigen (PSA) testing by human immunodeficiency virus (HIV) status and fit multivariable Poisson models comparing the rates of PSA testing, prostate biopsy, and cancer incidence. RESULTS: The mean age at enrollment was 52 years. Rates of PSA testing were lower in PWH versus uninfected comparators (0.58 versus 0.63 tests per person-year). Adjusted rates of PSA screening and prostate biopsy were lower among PWH (incidence rate ratio [IRR] 0.87, 95% CI 0.75-0.84 and IRR 0.79 95% CI 0.74-0.83, respectively). The crude IRR for prostate cancer was lower in PWH versus controls (IRR 0.90, 95% CI 0.83-0.97). However, in a multivariable model adjusting for PSA testing, cancer incidence was similar by HIV status (IRR=0.93, 95% CI 0.86-1.01, p=0.08). Among patients who received a prostate biopsy, incidence of prostate cancer did not differ significantly by HIV status (IRR 1.06, 95% CI 0.98-1.15, p=0.15). Among incident cancers, there were significant differences in the distributions of Gleason grade (p=0.05), but not cancer stage (p=0.14) by HIV status. CONCLUSIONS: When accounting for less PSA testing among PWH, the incidence of prostate cancer was similar by HIV status. These findings suggest that less screening contributed to lower observed incidence of prostate cancer in PWH.

来源:J Urol,查看原文。版权归原作者所有。

引用

  1. Leapman MS, Stone K, Wadia R, et al. Prostate Cancer Screening and Incidence among Aging Persons Living with HIV. J Urol. 2021. PMID: 34555924. doi:10.1097/JU.0000000000002249

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。